GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BioAmber Inc (FRA:7BA) » Definitions » Total Equity

BioAmber (FRA:7BA) Total Equity : €18.47 Mil (As of Dec. 2017)


View and export this data going back to 2013. Start your Free Trial

What is BioAmber Total Equity?

BioAmber's total equity for the quarter that ended in Dec. 2017 was €18.47 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

BioAmber Total Equity Historical Data

The historical data trend for BioAmber's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioAmber Total Equity Chart

BioAmber Annual Data
Trend Jun10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Total Equity
Get a 7-Day Free Trial 49.01 45.48 42.55 45.97 18.47

BioAmber Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.97 60.87 61.43 89.60 18.47

BioAmber Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BioAmber's Total Equity for the fiscal year that ended in Dec. 2017 is calculated as

Total Equity=Total Assets(Q: Dec. 2017 )-Total Liabilities(Q: Dec. 2017 )
=58.739-40.274
=18.47

BioAmber's Total Equity for the quarter that ended in Dec. 2017 is calculated as

Total Equity=Total Assets(Q: Dec. 2017 )-Total Liabilities(Q: Dec. 2017 )
=58.739-40.274
=18.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioAmber Total Equity Related Terms

Thank you for viewing the detailed overview of BioAmber's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioAmber (FRA:7BA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BioAmber Inc (FRA:7BA) » Definitions » Total Equity
Comparable Companies
BOM:524564 XCNQ:OPC BOM:524156 BOM:506858 BOM:524488 BOM:524522 BOM:524408 BOM:538634 NSE:PROLIFE BOM:526971 BOM:506520 BOM:524748 BOM:524640 SGX:5HH BOM:500358 TSXV:IPD BOM:539195 BOM:530991 BOM:524210 BOM:524514
Traded in Other Exchanges
N/A
Address
1250 Rene Levesque West, Suite 4310, Montreal, QC, CAN, H3B 4W8
Website
http://www.bio-amber.com
BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints, food additives and personal care products. BioAmber produces bio-succinic acid at a facility in Sarnia, Ontario, pursuant to a joint venture agreement with Mitsui. Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

BioAmber (FRA:7BA) Headlines

No Headlines